PureTech Health (LON:PRTC) Insider Purchases £37,462.39 in Stock

PureTech Health plc (LON:PRTC) insider Michele Holcomb acquired 31,481 shares of PureTech Health stock in a transaction dated Wednesday, July 8th. The stock was bought at an average price of GBX 119 per share, with a total value of £37,462.39.

PureTech Health Trading Up 1.6%

Shares of LON:PRTC opened at GBX 120 on Thursday. The stock has a 50 day moving average of GBX 129.88 and a 200 day moving average of GBX 127.13. The company has a market cap of £292.10 million, a PE ratio of -2.61 and a beta of 0.79. The company has a current ratio of 6.59, a quick ratio of 2.51 and a debt-to-equity ratio of 6.33. PureTech Health plc has a 12-month low of GBX 104.71 and a 12-month high of GBX 148.

About PureTech Health

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia.